Quick Answer
Sigyn Therapeutics, Inc. reported Total Revenue of $143.3 thousand for fiscal year 2019.
Sigyn Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2019 | $143.3K | +405.6% |
| 2018 | $28.3K | -26.2% |
| 2017 | $38.4K | +31.6% |
| 2015 | $29.2K | -32.3% |
| 2014 | $43.2K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2020 | $3.8K | -88.1% | +407.1% |
| March 31, 2020 | $756.00 | -98.2% | -97.6% |
| September 30, 2019 | $32.1K | -64.5% | -50.1% |
| June 30, 2019 | $64.3K | +1014.9% | +54.8% |
| March 31, 2019 | $41.6K | +79.5% | -54.1% |
| September 30, 2018 | $90.5K | -64.7% | +1467.6% |
| June 30, 2018 | $5.8K | -98.7% | -75.1% |
| March 31, 2018 | $23.1K | -91.4% | -91.0% |
- Sigyn Therapeutics, Inc. showed an increase of +405.6% in Total Revenue compared to the prior fiscal year.
- Over the 2014–2019 period, Sigyn Therapeutics, Inc.’s total revenue has grown by 232.1% (from $43.2 thousand to $143.3 thousand).
- The most recent figure is from Sigyn Therapeutics, Inc.’s fiscal year 2019 report (Form 10-K), filed with the SEC on March 30, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: